1 / 7

Next Generation Sequencing Market Future Challenges, Forecast 2032

The Global Next Generation Sequencing Market study focuses major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. It provides information on trends and developments, and focuses on markets and materials, capacities and technologies, and on the changing structure.

energy010
Download Presentation

Next Generation Sequencing Market Future Challenges, Forecast 2032

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Next Generation Sequencing Market Analysis & Forecast to 2032 by Key Players, Share, Trend, Segmentation

  2. Industry Insights • Next-generation sequencing (NGS) market is set to witness substantial growth through 2032 owing to the increasing use of the technology for diverse pharmaceutical & biopharmaceutical applications. • Developed economies worldwide with state-of-the-art biotech solutions are using NGS for drug discovery and development. • The emergence of novel diseases and the high prevalence of terminal illnesses with no promising cure have fueled the need for advanced therapies. • For instance, NGS has emerged as a pivotal tool in clinical oncology and cancer diagnostics. It helps detect variants at an ultra-sensitive and precise level, offering groundbreaking cancer diagnosis and care.

  3. Retinoblastoma (RB), and lung cancer diagnosis are some of the prominent areas where NGS has gained momentum. As per the American Cancer Society's 2023 estimates, the U.S. is projected to have more than 238,300 new cases of lung cancer and mortality of over 127,000 deaths. • Leading biotech and pharma companies are accelerating innovation and development in the field of cancer diagnostics therapeutics with the help of NGS. • For instance, in January 2023, Thermo Fisher Scientific announced a partnership with AstraZeneca to design a solid tissue & blood-based companion diagnostic (CDx) test for Tagrisso, a targeted cancer drug used to treat patients with non-small cell lung cancer. • The duo will use a fully-integrated NGS platform, Genexus Dx System to access the Oncomine Dx Express Test, featuring smart specimen-to-report workflow offering test results within 24 hours. As a result, a growing collaboration between industry players and new product launches will augment market growth.

  4. Regional Analysis • From a regional frame of reference, the Asia Pacific NGS market size will exceed USD 10 billion by 2032 due to the rise in healthcare infrastructure development across India, and China. Additionally, promising cost of genome sequencing, technological breakthroughs in WGS, and the increasing number of R&D facilities and research centers in APAC will propel industry growth. • Competitive Analysis • 10X Genomics, BGI, Agilent Technologies, Inc., Bio-Rad Laboratories, GenapSys Inc., F Hoffmann-La Roche, Illumina, Inc., Oxford Nanopore Technologies, NanoString Technologies, Inc., Pacific Biosciences of California, Inc., Qiagen, PerkinElmer Inc., and Thermo Fisher Scientific are some top participants profiled in the market.

  5. Next Generation Sequencing Market @ https://www.gminsights.com/industry-analysis/next-generation-sequencing-market Request for sample of this research report @ https://www.gminsights.com/request-sample/detail/3247 Request for customization @ https://www.gminsights.com/roc/3247

  6. Stay In Touch Social Media:

  7. THANK YOU www.gminsights.com

More Related